Search
for
Sort by
Research 601–630 of 1000+
- Stem cells supporting other stem cells
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Treating Alopecia Areata: Current Practices Versus New Directions
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Alopecia Areata: An Update on Treatment Options for Children
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Alopecia in general medicine
- Stem Cell Competition for Niche Occupancy: Emerging Themes and Mechanisms
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Alopecia areata – Current understanding and management
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Mechanisms of autophagy and their implications in dermatological disorders
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events